Efficacy of Aumolertinib in EGFR T790M-negative or -unknown NSCLC with Brain Metastases Following Resistance to Prior EGFR-TKIs

C. B. Han, Z. X. Dai,B. Jin, W. Cui,L. Man, H. J. Zhang

JOURNAL OF THORACIC ONCOLOGY（2023）

Cited 0|Views5

Key words

Aumolertinib,Brain Metastases,EGFR T790M-negative or unknown

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined